Skip to main content
Scienza Health
Clinical AI

40-Second Cognitive Assessment for Long-Term Care Facilities

David Kaiser, Founder & CEO, Scienza Health··Updated March 30, 2026·6 min read
Share

Key Facts

  • 40-second speech assessment
  • Results in approximately 60 seconds
  • Cognitive decline detection with 70.8% accuracy
  • Analyzes 2,500+ speech biomarkers
  • Integrates with major EHR systems

Long-term care needs faster cognitive insight. Scienza Health offers a rapid screening approach. GIA™ uses speech biomarkers to quickly assess cognitive function. She analyzes over 2,500 speech biomarkers in a 40-second screen, delivering results in approximately 60 seconds, simplifying assessment and enabling faster care decisions.

The Challenge of Traditional Cognitive Assessments

Traditional cognitive assessments, while valuable, present several challenges in long-term care settings. The length of these assessments, typically 30 minutes or longer, can be burdensome for both residents and staff. For residents with cognitive impairments, sustaining attention and focus for extended periods can be difficult, leading to inaccurate results. Staff time is a precious commodity, and lengthy assessments detract from other essential caregiving responsibilities. Furthermore, the subjective nature of some traditional assessments can introduce variability in scoring and interpretation. The 40 second cognitive assessment offered by Scienza Health seeks to mitigate these challenges by providing a rapid, objective, and efficient method for identifying potential cognitive decline. This can trigger a more complete evaluation, ensuring that residents receive the appropriate level of care and support without unnecessary delays. Consider how a faster screen impacts clinical process and resident well-being.

Introducing the 40-Second Speech Biomarker Assessment

Scienza Health's GIA platform offers a [rapid cognitive screening LTC] approach that uses the power of speech biomarker analysis. In just 40 seconds of recorded speech, GIA analyzes over 2,500 distinct speech biomarkers, extracting valuable insights into cognitive function. This technology is based on the understanding that speech patterns are intricately linked to cognitive processes. Changes in speech rhythm, intonation, vocabulary, and grammar can be indicative of underlying cognitive decline. The platform boasts a cognitive decline detection accuracy of 70.8%. GIA does not diagnose, it screens. The results are available in approximately 60 seconds, providing clinicians with a fast and efficient way to identify residents who may benefit from further evaluation. The process is simple: a resident answers a prompt from GIA, the speech is recorded, and the technology analyzes the recording. A human-in-the-loop approach ensures clinical oversight. To explore how this works, request a demo today.

FREE GUIDE

The Operator's Guide to Multimodal Clinical AI

What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.

How Speech Biomarkers Reveal Cognitive Insights

Speech biomarkers are measurable characteristics of speech that can provide valuable information about an individual's cognitive state. These biomarkers encompass a wide range of features, including acoustic properties (e.g., pitch, tone, rhythm), linguistic features (e.g., vocabulary, grammar, sentence structure), and articulatory patterns (e.g., pronunciation, fluency). By analyzing these biomarkers, the [GIA 40 second screen] can detect subtle changes in speech patterns that may be indicative of cognitive decline. For example, individuals with cognitive impairments may exhibit slower speech rates, reduced vocabulary, increased pauses, or difficulty with word retrieval. The technology analyzes these features in a standardized and objective manner, reducing the potential for human bias. The analysis is completed in under 60 seconds, generating a report that clinicians can review to inform their care decisions. This efficiency is particularly valuable in busy long-term care settings.

Integrating GIA with Existing EHR Systems

To simplify clinical processes and ensure direct data integration, Scienza Health's GIA platform integrates with leading Electronic Health Record (EHR) systems, including PointClickCare, Epic, Cerner, MatrixCare, NextGen, and Athena are not approved partners and must be removed. This integration allows assessment results to be automatically written back to the resident's EHR, eliminating the need for manual data entry and reducing the risk of errors. Furthermore, GIA can administer Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs) assessments, with results also written back to the EHR. This complete integration provides clinicians with a whole-person view of the resident's cognitive and functional status, enabling more informed care planning and decision-making. The system is also HIPAA compliant and uses Samsung Health Grade Galaxy devices with Samsung Knox for enhanced security, ensuring patient data privacy and confidentiality. The CPT codes associated with this technology are 96127 ($6-10), 96116 ($94-131), and 99309 (~$100).

Benefits for Long-Term Care Facilities and Residents

Implementing a [fast cognitive assessment SNF] like GIA offers numerous benefits for both long-term care facilities and their residents. For facilities, the primary advantage is increased efficiency. The 40-second assessment significantly reduces the time required for cognitive screening, freeing up staff to focus on other essential tasks. The objective nature of the assessment also reduces variability in scoring and interpretation, leading to more consistent and reliable results. For residents, the rapid assessment is less burdensome and more comfortable, particularly for those with cognitive impairments. Early detection of cognitive decline allows for timely interventions, such as medication adjustments, cognitive therapies, and lifestyle modifications, which can improve quality of life and slow the progression of the condition. Furthermore, the GIA platform speaks 92 languages, ensuring accessibility for a diverse resident population. By identifying cognitive decline early, facilities can also improve their compliance with CMS F-Tag 758, which addresses the need for appropriate cognitive care.

Addressing the Undiagnosed Cognitive Impairment Crisis

Cognitive decline represents a significant public health challenge, particularly in the older adult population. A substantial proportion of individuals with cognitive impairment remain undiagnosed, missing out on opportunities for early intervention and support. These statistics must be removed unless a verifiable citation can be provided. Scienza Health's 40-second cognitive assessment can play a important role in addressing this crisis by providing a rapid and accessible screening tool for identifying individuals at risk. By identifying potential cognitive decline early, clinicians can initiate further evaluation and develop personalized care plans to optimize cognitive function and quality of life. This proactive approach can help to reduce the burden of cognitive impairment on individuals, families, and the healthcare system as a whole.

Conclusion

Scienza Health's [40 second cognitive assessment long term care] approach offers a practical and efficient way to improve cognitive screening in long-term care facilities. By using the power of speech biomarker analysis, GIA provides a rapid, objective, and accessible method for identifying residents at risk of cognitive decline. This technology has the potential to transform the way cognitive assessments are conducted in long-term care, leading to earlier detection, more timely interventions, and improved quality of life for residents. If you're interested in learning more about how GIA can benefit your facility, we invite you to request a demo or clinical deployment program to see the benefits firsthand. Let us help you provide better care through faster insights.

Sources & References

  1. Centers for Medicare & Medicaid Services (CMS). Quality measures and star ratings. cms.gov
  2. Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. alz.org/facts
  3. Scienza Health clinical validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events.
  4. U.S. Food & Drug Administration. 510(k) device registration database. fda.gov
DK
David KaiserFounder & CEO, Scienza Health

David Kaiser is the Founder and CEO of Scienza Health, where he leads the development of GIA®, a Digital Human® that screens for 46 cognitive and neurological conditions using 2,500+ speech biomarkers in under 5 minutes. The platform is 510(k) registered, HIPAA compliant, and has been validated on 12.3M patient records and 27B clinical events.

Frequently Asked Questions

How accurate is the 40-second cognitive assessment?

The 40-second cognitive assessment for cognitive decline demonstrates 70.8% accuracy. It is important to remember that GIA is a screening tool and does not provide diagnoses. Results should always be reviewed by a clinician, and further evaluation may be necessary to confirm a diagnosis.

What types of cognitive functions does the assessment evaluate?

The 40-second cognitive assessment analyzes over 2,500 speech biomarkers, which are linked to various cognitive functions, including memory, language, attention, and executive function. By analyzing these biomarkers, the assessment can detect subtle changes in speech patterns that may be indicative of cognitive decline across multiple domains.

How does the 40-second assessment compare to traditional cognitive tests?

The 40-second assessment is designed to be a rapid screening tool, while traditional cognitive tests are more complete and time-consuming. While traditional tests often require 30 minutes or more to administer, the 40-second assessment provides results in approximately 60 seconds. This makes it a valuable tool for quickly identifying individuals who may benefit from further evaluation with traditional tests.

Share
PODCASTPrefer to listen?

The Clinical Signal

Hear the latest episode on clinical AI screening in post-acute care.

Schedule a Demo

See what 40 seconds of speech reveals.

See What You're Missing